Gallstones Clinical Trial
Official title:
Safety and Feasibility Trial of Laparoscopic Small Port Cholecystectomy With Transgastric Gallbladder Recovery
The benefits of laparoscopic ("minimally invasive" or "keyhole") surgery for gallbladder removal (cholecystectomy) over open surgical procedures in terms of significant reductions in pain, scarring and recovery time are well accepted. In a conventional laparoscopic cholecystectomy however, the excised gallbladder still has to be extracted through the abdominal wall skin via a laparoscopic port site using an incision of 10mm or greater. Despite being much smaller than that required for open surgery, this incision is painful, leaves a scar and can result in a port site hernia to follow requiring further surgery to repair it. Recent attempts to further reduce the invasiveness of the surgical procedure have suggested performing the operation via an endoscope passed through the mouth and through an incision in the stomach wall - so called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Unlike a skin incision, an incision in the wall of the stomach (gastrotomy) should give no pain, visible scar or herniation risk yet still allow access to the peritoneal cavity for surgical procedures such as cholecystectomy. Against this, it has the potential risks of contamination and leakage of gastric contents into the peritoneal cavity. Whilst the limitations of present technology make it very difficult to perform an entire cholecystectomy through the stomach wall in patients, endoscopic methods for closing a gastrotomy are available that are approved for use in patients (CE marked) and it is hypothesised that removing the excised gallbladder through the stomach in this way would avoid the problems of extracting it through the abdominal wall described above. Data are required to determine whether the extraction of the gallbladder via a gastrotomy rather than through the skin is safe, producing smaller scars and a better cosmetic result. A secondary endpoint would be to assess possible reductions in pain and recovery from this less invasive approach.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Fit patients, avoiding extremes of age, with uncomplicated gallstone disease requiring elective laparoscopic cholecystectomy. Exclusion Criteria: - Direct healthcare team deny permission to approach patient for trial. - Patient request / preference. - Age (< 21 or > 65 yrs old). - Co-morbidity (ASA level 3 or above). - BMI > 32. - Complicated gallstone disease (eg bile duct stones/ERCP/pancreatitis). - Gallstones = 18 mm size (too large to recover via oesophagus). - Pregnancy. - Previous gastric or upper abdominal surgery (alterations in gastric anatomy or adhesions preventing safe gastrotomy). - Emergency procedure. - Planned other operation during cholecystectomy. - Inability to consent or psychiatric or addiction problems relevant to surgery. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | Colchester General Hospital | Colchester | Essex |
Lead Sponsor | Collaborator |
---|---|
Colchester Hospital University NHS Foundation Trust | Ethicon, Inc. |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | This is a pilot study aimed at examining the outcomes of gallbladder recovery through a gastrotomy, concentrating on safety. The main outcome is presence of surgical complications. | 6 months | Yes | |
Secondary | Secondary outcomes include pain levels and cosmetic satisfaction | 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01625026 -
Obeticholic Acid in Bariatric and Gallstone Disease
|
Phase 2 | |
Completed |
NCT00530998 -
Minimally Invasive Surgery: Using Natural Orfices
|
||
Completed |
NCT02858986 -
3D Versus 4K Laparoscopic Cholecystectomy
|
N/A | |
Active, not recruiting |
NCT05592795 -
Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
|
||
Terminated |
NCT02325492 -
Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study
|
Phase 2 | |
Completed |
NCT02469935 -
Accuracy of Surgeon-performed Ultrasound in Detecting Gallstones - a Validation Study
|
N/A | |
Withdrawn |
NCT01232959 -
Feasibility of Transvaginal Cholecystectomy
|
N/A | |
Completed |
NCT01190280 -
Indications for Gallbladder Surgery in Gallstone Disease
|
Phase 3 | |
Withdrawn |
NCT00460980 -
Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model
|
N/A | |
Completed |
NCT02344654 -
Fluorescence Cholangiography During Cholecystectomy - a RCT
|
N/A | |
Completed |
NCT00528632 -
Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides
|
N/A | |
Recruiting |
NCT03891147 -
A Clinical Trial of Electro-acupuncture for Treating Gallstone Diseases
|
N/A | |
Not yet recruiting |
NCT06385860 -
Prediction Model for Early Biliary Stasis After Bariatric Surgery
|
||
Completed |
NCT02831556 -
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
|
||
Completed |
NCT02947256 -
Laparoscopic Cholecystectomy With Retro-infundibular Approach
|
Phase 2 | |
Recruiting |
NCT01438385 -
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
|
N/A | |
Completed |
NCT01410734 -
Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively)
|
N/A | |
Withdrawn |
NCT00240123 -
Effect of Benadryl Sedation During ERCP or EUS
|
Phase 1 | |
Completed |
NCT03809559 -
Repeatability and Reproducibility of Quantitative MRCP
|
||
Recruiting |
NCT01822262 -
Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy
|
Phase 4 |